aTyr Pharma (ATYR)
(Delayed Data from NSDQ)
$3.04 USD
-0.08 (-2.56%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $3.02 -0.02 (-0.66%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$3.04 USD
-0.08 (-2.56%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $3.02 -0.02 (-0.66%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Zacks News
C4 Therapeutics, Inc. (CCCC) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
C4 Therapeutics (CCCC) delivered earnings and revenue surprises of 12.50% and 158.10%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Is aTyr Pharma (ATYR) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Here is how Atyr Pharma (ATYR) and High Tide Inc. (HITI) have performed compared to their sector so far this year.